Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avignon

Showing results (171-180 of 200) with videos related to

Pageof 20
Sort By:
Obesity (Silver Spring, Md.)|November 6, 2023
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgeryJean-Baptiste Bonnet, Sarah Tournayre, Jean Anitcheou, et al.
Endocrine Connections|May 6, 2022
In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alterationLaurent Maïmoun, Denis Mariano-Goulart, Helena Huguet, et al.
Obesity (Silver Spring, Md.)|April 3, 2025
Clustering of intuitive eating and psychological health identifies subgroups associated with weight loss following semaglutideAntoine Avignon, Jean-Baptiste Bonnet, Jean Anitcheou, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|September 19, 2024
NursPainPrevent: A Prospective Observational Study on Pain During a Bed BathBénédicte Lombart, Patricia Cimerman, Céline Guiot, et al.
Bone|May 16, 2021
Modification of bone mineral density, bone geometry and volumetric BMD in young women with obesityLaurent Maïmoun, Eric Renard, Ludovic Humbert, et al.
Diabetes & Metabolism|February 19, 2025
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety dataEmmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, et al.
Medicina (Kaunas, Lithuania)|December 24, 2021
Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology UnitsLaura Lohan, Florence Galtier, Thibault Manson, et al.
Nature Biomedical Engineering|December 19, 2023
Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroidsMarius F Harter, Timothy Recaldin, Regine Gerard, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety ProfilingAnnie Moisan, Marcel Gubler, Jitao David Zhang, et al.
The International Journal of Behavioral Nutrition and Physical Activity|May 21, 2026
The mind-eat program leads to greater improvements in mindful, emotional, and external eating compared to intuitive eating-oriented education in adults with overweight or obesity: a randomized controlled trialMarion Van Beekum, Angélique Rodhain, Rebecca Shankland, et al.
Pageof 20

Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
Obesity (Silver Spring, Md.)|November 6, 2023
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgeryJean-Baptiste Bonnet, Sarah Tournayre, Jean Anitcheou, et al.
Endocrine Connections|May 6, 2022
In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alterationLaurent Maïmoun, Denis Mariano-Goulart, Helena Huguet, et al.
Obesity (Silver Spring, Md.)|April 3, 2025
Clustering of intuitive eating and psychological health identifies subgroups associated with weight loss following semaglutideAntoine Avignon, Jean-Baptiste Bonnet, Jean Anitcheou, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|September 19, 2024
NursPainPrevent: A Prospective Observational Study on Pain During a Bed BathBénédicte Lombart, Patricia Cimerman, Céline Guiot, et al.
Bone|May 16, 2021
Modification of bone mineral density, bone geometry and volumetric BMD in young women with obesityLaurent Maïmoun, Eric Renard, Ludovic Humbert, et al.
Diabetes & Metabolism|February 19, 2025
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety dataEmmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, et al.
Medicina (Kaunas, Lithuania)|December 24, 2021
Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology UnitsLaura Lohan, Florence Galtier, Thibault Manson, et al.
Nature Biomedical Engineering|December 19, 2023
Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroidsMarius F Harter, Timothy Recaldin, Regine Gerard, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety ProfilingAnnie Moisan, Marcel Gubler, Jitao David Zhang, et al.
The International Journal of Behavioral Nutrition and Physical Activity|May 21, 2026
The mind-eat program leads to greater improvements in mindful, emotional, and external eating compared to intuitive eating-oriented education in adults with overweight or obesity: a randomized controlled trialMarion Van Beekum, Angélique Rodhain, Rebecca Shankland, et al.
Pageof 20